PubMed HealthSearch

Biomedical subjects

Lu Ren

Publications and source records attributed to Lu Ren.

2 recordsLinked to original sources

Highly Conserved Allelic Substitutions S202F, L244P, and H248P/R/Y in FsSdhB and A83 V in FsSdhC1 Trigger Gradual Resistance to Pydiflumetofen in Fusarium solani.

Pydiflumetofen (Pyd), one of the new-generation SDHIs, has been applied to control various diseases in economic crops. Fusarium solani, a soil-borne pathogen with a broad host range, is the agent of quinoa basal-stem rot (QBSR). In this study, three PydLR (4.64 < RF < 9.31), six PydMR (51.24 < RF < 86.91), and seven PydHR mutants (RF > 6000) were generated by Pyd-taming. Most F. solani PydR mutants showed no fitness penalties. The sequence alignment of FsSdh genes revealed that substitutions S202F, L244P, and H248P/R/Y in FsSdhB, or A83 V in FsSdhC1, caused Pyd resistance. Notably, the mutation S202F causing HR was first reported. Molecular docking demonstrated that these aforementioned mutations significantly reduced affinity between Pyd and the Qp-binding pocket. These results provide pivotal data for the resistance management strategies of F. solani and advance our understanding of the resistance mechanisms of SDHIs.

Fusarium

RADX protects against intestinal inflammation by restraining IFI16-mediated innate immunity.

Genomic instability is increased in patients with inflammatory bowel disease (IBD), yet whether it contributes directly to disease pathogenesis remains unclear. Here, we identify RADX, a structural antagonist to RAD51 and a key regulator of replication fork stability, as a critical suppressor of intestinal inflammation by limiting innate immune sensing of replication-associated DNA damage. RADX deficiency exacerbates experimental colitis, with macrophages serving as the principal mediators of this phenotype. Mechanistically, RADX competes with the DNA sensor IFI16 for binding to single-stranded DNA (ssDNA). Loss of RADX promotes ssDNA accumulation, triggering IFI16-dependent activation of NF-&#x3ba;B signaling and inflammasome assembly, thereby driving intestinal inflammation. Consistent with these findings, two RADX variants identified in patients with IBD associate with reduced RADX protein expression, increased DNA damage signaling, and elevated IL-1&#x3b2; levels. Pharmacological inhibition of RAD51 with RI-1 alleviated colitis in both wild-type and Radx-deficient mice. Together, these findings establish a mechanistic link between genome instability and intestinal inflammation, identify a RADX-IFI16 checkpoint that restrains pathogenic innate immune activation, and nominate modulation of replication stress as a therapeutic strategy for IBD.

Animals